Latest News Archive
Please select Category, Year, and then Month to display items
03 January 2023
|
Story Lacea Loader
|
Photo Evert Kleynhans
Dr Dolf van Niekerk.
The University of the Free State (UFS) would like to express its condolences to the family and friends of South African author, Dr Dolf van Niekerk, on his passing.
Dr Van Niekerk, the recipient of an
honorary doctorate from the UFS, passed away on 31 December 2022. The UFS awarded a Doctor of Letters to Dr Dolf van Niekerk during its April 2021 graduation ceremony.
Dr Van Niekerk was a celebrated author who also achieved fame as a dramatist and radio presenter. An alumnus of the UFS, he received a BA degree from the university cum laude in 1949. He also played a role in academia and was an emeritus professor at the University of Pretoria until his retirement in 1994. His work includes 27 books in philosophy, poetry, fiction, drama, and memoirs, for which he has received numerous awards. These include the
Eugene Marais Prize, the MER Prize, and the Scheepers Award for Youth Literature.
“Dr van Niekerk is a Kovsie alumnus with a deep connection to the Free State. He played a significant role in the country’s literary history, and it was an honour for the university to award him with an honorary degree. A wordsmith of note, Dr van Niekerk’s contributions to South African literature, radio, and stage will live on," says
Prof Francis Petersen, Rector and Vice-Chancellor.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004